DexCom (NASDAQ:DXCM) Price Target Raised to $103.00
DexCom (NASDAQ:DXCM – Get Free Report) had its target price boosted by investment analysts at Canaccord Genuity Group from $99.00 to $103.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the medical device company’s stock. Canaccord Genuity Group’s price target points to a […]
More Stories
KBC Group NV Has $408,000 Position in OGE Energy Corporation (NYSE:OGE)
KBC Group NV grew its holdings in OGE Energy Corporation (NYSE:OGE – Free Report) by 13.8% during the 1st quarter,...
KBC Group NV Acquires 4,019 Shares of SoFi Technologies, Inc. (NASDAQ:SOFI)
KBC Group NV raised its holdings in shares of SoFi Technologies, Inc. (NASDAQ:SOFI – Free Report) by 9.9% in the...
Safe & Green (NASDAQ:SGBX) vs. Mohawk Industries (NYSE:MHK) Head-To-Head Contrast
Mohawk Industries (NYSE:MHK – Get Free Report) and Safe & Green (NASDAQ:SGBX – Get Free Report) are both consumer discretionary...
Mirae Asset Global Investments Co. Ltd. Invests $1.25 Million in Nebius Group N.V. (NASDAQ:NBIS)
Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Nebius Group N.V. (NASDAQ:NBIS – Free Report)...
Sequoia Financial Advisors LLC Sells 558 Shares of Global X Silver Miners ETF (NYSEARCA:SIL)
Sequoia Financial Advisors LLC lessened its stake in Global X Silver Miners ETF (NYSEARCA:SIL – Free Report) by 8.8% in...
Mirae Asset Global Investments Co. Ltd. Boosts Holdings in City Holding Company (NASDAQ:CHCO)
Mirae Asset Global Investments Co. Ltd. increased its stake in shares of City Holding Company (NASDAQ:CHCO – Free Report) by...